Name | (R)-GNE-140 |
---|---|
Synonyms | MFCD31560470 |
Description | (R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor, with IC50s of 3 nM and 5 nM for LDHA and LDHB, respectively; (R)-GNE-140 is 18-fold more potent than S enantiomer. |
---|---|
Related Catalog | |
Target |
IC50: 3 nM (LDHA), 5 nM (LDHB)[1] |
In Vitro | (R)-GNE-140 inhibits proliferation in 37 of 347 cancer cell lines tested at a potency cut off of 5 μM. (R)-GNE-140 shows inhibitory effect on two chondrosarcoma (bone) cancer cell lines that harbor IDH1 mutations, with IC50 of 0.8 μM[1]. |
In Vivo | (R)-GNE-140 (5 mg/kg) has high bioavailability in mice. At higher oral doses, ranging from 50 to 200 mg/kg, (R)-GNE-140 displays greater exposure. |
References |
Molecular Formula | C25H23ClN2O3S2 |
---|---|
Molecular Weight | 499.04 |
Storage condition | -20℃ |